The Engine of Chronic Care: Factors Driving Gastrointestinal Drugs Market Growth and Global Disease Prevalence
The sustained Gastrointestinal Drugs Market growth is powerfully driven by the non-discretionary nature of treating chronic and often debilitating GI disorders. A key driver is the escalating global prevalence of IBD, GERD, and chronic constipation, directly linked to lifestyle factors such as stress, processed diets, and reduced physical activity across both developed and rapidly developing...
0 Kommentare 0 Anteile 766 Ansichten 0 Vorschau